サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1787176

サル痘検査の世界市場

Monkeypox Testing

出版日
ページ情報
英文 279 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
サル痘検査の世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 279 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

サル痘検査の世界市場は2030年までに1億4,800万米ドルに達する見込み

2024年に1億2,220万米ドルと推定されるサル痘検査の世界市場は、2024年から2030年にかけてCAGR 3.2%で成長し、2030年には1億4,800万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるポリメラーゼ連鎖反応技術は、CAGR 4.2%を記録し、分析期間終了までに8,330万米ドルに達すると予測されます。ラテラルフローアッセイ技術分野の成長率は、分析期間中CAGR 2.0%と推定されます。

米国市場は3,330万米ドルと推定、中国はCAGR6.3％で成長予測

米国のサル痘検査市場は、2024年に3,330万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2,960万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.2％と2.5％と予測されています。欧州では、ドイツがCAGR 1.8%で成長すると予測されています。

世界のサル痘検査市場- 主要動向と促進要因のまとめ

サル痘検査の需要が近年急増しているのはなぜか？

世界のサル痘の流行により、ウイルスの蔓延を食い止めるための迅速で信頼性の高い診断検査の必要性が浮き彫りになりました。サル痘はサル痘ウイルスによって引き起こされるウイルス性人獣共通感染症で、発熱、皮膚病変、リンパ節の腫れなど天然痘に似た症状を示します。世界的に感染者が増加する中、政府やヘルスケア機関は感染の早期発見と隔離措置を実施するため、検査への取り組みを強化しています。特に都市部や人口密度の高い地域では、ウイルスの感染性が高いため、診断検査に対する需要が高まっています。さらに、無症状で軽度の症例が出現していることから、目に見える症状がなくても感染を正確に検出できる高感度分子検査の必要性が浮き彫りになっています。世界の渡航の拡大と経済の相互接続は、サル痘の蔓延をさらに加速させ、広範な検査の緊急の必要性を促しています。

どのような技術革新がサル痘検査の能力を高めているのか？

高度な診断技術の開発は、サル痘検査の精度とスピードの向上に重要な役割を果たしています。リアルタイムポリメラーゼ連鎖反応（RT-PCR）のような分子ベースの方法は、その高い感度と特異性により、サル痘を検出するためのゴールドスタンダードとなっています。迅速抗原検査もまた、高リスク集団における迅速スクリーニングのためのポイント・オブ・ケアソリューションを提供するために開発されています。さらに、次世代シークエンシング（NGS）は、ウイルスの変異を追跡し、伝播パターンを理解するために活用されています。診断ツールに人工知能（AI）を組み込むことで、検査結果の解釈効率がさらに向上し、ヘルスケア専門家の作業負担が軽減されています。家庭用検査キットも、アクセス性を向上させ、脆弱なコミュニティにおける自己監視を奨励するために検討されています。

政府の規制と公衆衛生への取り組みは市場にどのような影響を与えているか？

世界各国の政府や保健機関は、サル痘の発生を抑制するために広範な検査戦略を実施しており、診断ソリューションの需要を煽っています。世界保健機関（WHO）、疾病対策予防センター（CDC）、その他の世界の保健機関は、検査プロトコルに関するガイドラインを発表し、検査施設インフラへの投資拡大を推進しています。各国政府はまた、ヘルスケア環境への展開を加速させるため、新しい検査キットの規制当局による承認を迅速に進めています。早期発見と自己隔離を強調する公衆衛生キャンペーンは、手頃な価格で広く利用可能な検査オプションに対する需要の高まりに寄与しています。移動式検査ユニットや地域ベースのスクリーニング・プログラムの拡大が、市場の成長をさらに後押ししています。

サル痘検査市場の成長を促進する主な要因は何か？

サル痘検査市場の成長は、世界のアウトブレイクの増加、診断技術の進歩、政府による検査イニシアティブなど、いくつかの要因によって牽引されています。主な要因の1つは、感染症サーベイランスへの投資の増加であり、これが診断ラボや迅速検査インフラの拡大につながっています。PCRベースの検査の採用が増加し、ポータブルで迅速な抗原検査が開発されたことも、市場拡大に拍車をかけています。さらに、サル痘とその潜在的な長期的健康影響に対する意識の高まりが、特に高リスク集団における検査の普及を促しています。血清学的検査や家庭での検査ソリューションの研究が進んでいることから、市場に新たな機会が生まれると期待されています。ヘルスケアシステムが引き続き早期発見と封じ込めを優先していることから、サル痘検査市場は今後数年で大きく成長するものと思われます。

セグメント

技術（ポリメラーゼ連鎖反応技術、ラテラルフローアッセイ技術、その他の技術）、エンドユーザー（診断ラボ、病院・診療所、その他のエンドユーザー）

調査対象企業の例

  • Aegis Sciences Corporation
  • Applied DNA Clinical Labs, LLC
  • ARUP Laboratories
  • BayCare Laboratories, LLC
  • Baylor Scott & White Advanced Diagnostics Laboratory
  • BioReference Health, LLC
  • CDR Laboratories, Inc
  • Cepheid
  • Curative Labs
  • DevLab Bio
  • Fulgent Genetics
  • Houston Methodist Hospital Pathology
  • Integrity Laboratories, LLC
  • Ipsum Diagnostics LLC
  • Johns Hopkins Medical Microbiology Laboratory
  • Labcorp
  • Mayo Clinic Laboratories
  • Quest Diagnostics
  • Sonic Healthcare

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32212

Global Monkeypox Testing Market to Reach US$148.0 Million by 2030

The global market for Monkeypox Testing estimated at US$122.2 Million in the year 2024, is expected to reach US$148.0 Million by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Polymerase Chain Reaction Technology, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$83.3 Million by the end of the analysis period. Growth in the Lateral Flow Assay Technology segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$33.3 Million While China is Forecast to Grow at 6.3% CAGR

The Monkeypox Testing market in the U.S. is estimated at US$33.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$29.6 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Monkeypox Testing Market - Key Trends & Drivers Summarized

Why Has the Demand for Monkeypox Testing Surged in Recent Years?

The global outbreak of monkeypox has underscored the critical need for rapid and reliable diagnostic testing to contain the spread of the virus. Monkeypox, a viral zoonotic disease caused by the monkeypox virus, presents symptoms similar to smallpox, including fever, skin lesions, and swollen lymph nodes. With cases rising worldwide, governments and healthcare institutions have ramped up testing efforts to identify infections early and implement isolation measures. The demand for diagnostic testing has increased due to the highly transmissible nature of the virus, especially in urban and high-density population areas. Additionally, the emergence of asymptomatic and mild cases has highlighted the necessity for sensitive molecular tests that can accurately detect infections even in the absence of visible symptoms. The expansion of global travel and interconnected economies has further accelerated the spread of monkeypox, driving the urgent need for widespread testing.

What Technological Innovations Are Enhancing Monkeypox Testing Capabilities?

The development of advanced diagnostic techniques has played a crucial role in improving the accuracy and speed of monkeypox testing. Molecular-based methods such as real-time polymerase chain reaction (RT-PCR) have become the gold standard for detecting monkeypox due to their high sensitivity and specificity. Rapid antigen tests are also being developed to provide point-of-care solutions for quick screening in high-risk populations. Additionally, next-generation sequencing (NGS) is being utilized to track viral mutations and understand transmission patterns. The integration of artificial intelligence (AI) in diagnostic tools has further improved the efficiency of test result interpretation, reducing the workload on healthcare professionals. At-home testing kits are also being explored to increase accessibility and encourage self-monitoring in vulnerable communities.

How Are Government Regulations and Public Health Initiatives Influencing the Market?

Governments and health organizations worldwide have implemented extensive testing strategies to control monkeypox outbreaks, fueling demand for diagnostic solutions. The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and other global health agencies have issued guidelines on testing protocols, pushing for increased investment in laboratory infrastructure. Governments have also fast-tracked regulatory approvals for novel testing kits to accelerate deployment in healthcare settings. Public health campaigns emphasizing early detection and self-isolation have contributed to the rising demand for affordable and widely available testing options. The expansion of mobile testing units and community-based screening programs has further bolstered market growth.

What Are the Key Factors Driving Growth in the Monkeypox Testing Market?

The growth in the monkeypox testing market is driven by several factors, including increased global outbreaks, advancements in diagnostic technologies, and government-backed testing initiatives. One of the primary drivers is the rising investment in infectious disease surveillance, which has led to the expansion of diagnostic laboratories and rapid testing infrastructure. The increased adoption of PCR-based testing, coupled with the development of portable and rapid antigen tests, is further fueling market expansion. Additionally, growing awareness about monkeypox and its potential long-term health impacts has encouraged widespread testing, particularly in high-risk populations. The ongoing research into serological and at-home testing solutions is expected to create new opportunities in the market. As healthcare systems continue to prioritize early detection and containment, the monkeypox testing market is poised for significant growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Monkeypox Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Polymerase Chain Reaction Technology, Lateral Flow Assay Technology, Other Technologies); End-Use (Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Aegis Sciences Corporation
  • Applied DNA Clinical Labs, LLC
  • ARUP Laboratories
  • BayCare Laboratories, LLC
  • Baylor Scott & White Advanced Diagnostics Laboratory
  • BioReference Health, LLC
  • CDR Laboratories, Inc
  • Cepheid
  • Curative Labs
  • DevLab Bio
  • Fulgent Genetics
  • Houston Methodist Hospital Pathology
  • Integrity Laboratories, LLC
  • Ipsum Diagnostics LLC
  • Johns Hopkins Medical Microbiology Laboratory
  • Labcorp
  • Mayo Clinic Laboratories
  • Quest Diagnostics
  • Sonic Healthcare

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Monkeypox Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Incidences of Monkeypox Drive Accelerated Demand for Diagnostic Testing Solutions
    • Rising Awareness of Monkeypox Among Healthcare Providers Expands Addressable Market for Testing Solutions
    • Advancements in Molecular Diagnostic Technologies Propel Growth in Monkeypox Testing Accuracy and Speed
    • Strengthening Public Health Surveillance and Monitoring Initiatives Boost Demand for Monkeypox Testing Kits
    • Emergence of Monkeypox as a Public Health Concern Spurs Increased Government and Institutional Funding for Testing
    • Regulatory Approvals and Certification of New Diagnostic Tests Drive Market Confidence and Adoption
    • Expansion of Point-of-care Testing Solutions Enhances Accessibility and Speeds Monkeypox Diagnosis in Remote Areas
    • Increasing Focus on Global Preparedness for Emerging Infectious Diseases Strengthens Business Case for Monkeypox Testing
    • Surge in International Travel and Cross-border Movement Spurs Demand for Rapid Monkeypox Screening
    • Growing Need for Early Detection and Prevention of Monkeypox Increases Market Demand for Reliable Testing Platforms
    • Technological Advancements in PCR and Lateral Flow Assays Enhance Market Adoption for Monkeypox Testing Kits
    • Integration of Artificial Intelligence and Automation in Monkeypox Testing Improves Efficiency and Diagnostic Precision
    • Expanding Focus on Genomic Surveillance and Tracking of Monkeypox Strains Drives Demand for High-Throughput Testing
    • Increasing Healthcare Budgets and Investment in Diagnostic Infrastructure Strengthen the Market for Monkeypox Testing
    • Expansion of Telemedicine and Remote Healthcare Services Increases Adoption of At-home and Digital Monkeypox Testing Solutions
    • Rising Incidents of Monkeypox Outbreaks in High-Risk Populations Creates Urgency for Enhanced Testing Solutions
    • Public Health Initiatives and Education on Monkeypox Transmission Boost Demand for Testing Kits in Vulnerable Regions
    • Demand for Multiplex Testing Platforms that Can Simultaneously Detect Monkeypox and Other Viruses Expands Market Opportunity
    • Growing Collaboration Between Governments, NGOs, and the Private Sector Accelerates Market Expansion for Monkeypox Testing Solutions
    • Emerging Market Access and Distribution Channels for Monkeypox Testing Kits Strengthen Global Availability and Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Monkeypox Testing Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Monkeypox Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Monkeypox Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Monkeypox Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Polymerase Chain Reaction Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Polymerase Chain Reaction Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lateral Flow Assay Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Lateral Flow Assay Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Lateral Flow Assay Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Monkeypox Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Monkeypox Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Monkeypox Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Monkeypox Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Monkeypox Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Monkeypox Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Monkeypox Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Monkeypox Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Monkeypox Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Monkeypox Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Monkeypox Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION